Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America).

Feb 4, 2021 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021.

Oct 26, 2022 · He will succeed Kenneth C. Frazier, who plans to retire on Nov. 30, 2022, after a long-tenured career at Merck that began in 1992. Frazier led the company for 10 years as president and chief executive officer, from 2011 through 2021.

Jun 12, 2023 · Former CEO and executive chairman of Merck, Ken Frazier, offers candid reflections on how crises tested his commitment to values—both Merck’s and his own.

Oct 27, 2022 · Kenneth Frazier announced Wednesday afternoon that he will retire as Merck’s chairman of the board next month, ending a decades-long career at the pharma giant. Merck’s board of directors voted CEO and president Robert M. Davis to replace the outgoing Frazier effective December 1.

Feb 4, 2021 · Ken Frazier, who has been Merck & Co.’s chief executive since 2011, will retire June 30, the New Jersey pharma said Thursday. He will continue to serve as executive chairman for a transition...

Feb 4, 2021 · Merck Chief Executive Officer Kenneth C. Frazier is stepping down from his role atop the helm of the pharma giant on June 30 after nearly 30 years with the company. He will be replaced by Robert M. Davis, Merck’s chief financial officer and head of global services.

Feb 4, 2021 · Kenneth Frazier, the veteran CEO of Merck & Co. and one of the highest profile executives in the pharmaceutical industry, will step down as head of the 130-year-old drugmaker at the end of June, the company announced Thursday.

Feb 4, 2021 · Longtime Merck executive Ken Frazier, whose leadership helped bring the drugmaker one of the most lucrative medicines in history and who is one of the few remaining Black CEOs of a major corporation, is retiring.

Feb 4, 2021 · Merck’s outspoken chairman and CEO, Ken Frazier, is retiring after almost 30 years at the drugmaker, the company announced Thursday.